A broad review summarizing experimental and clinical evidence that disturbances in folate and one‑carbon metabolism are associated with neurodegenerative diseases.

Connects metabolism, homocysteine and methylation to neurodegeneration and highlights biomarker and repurposing opportunities (e.g., folate supplementation), but is non‑specific to Parkinson's and lacks clear, actionable therapeutic targets or novel PD‑focused data.